Category Archives for "News"

Abattis Enters into Definitive Share Exchange Agreement with Nutrivida

Abattis Enters into Definitive Share Exchange Agreement with Nutrivida January 10, 2019    |    Abattis Bioceuticals VANCOUVER, BRITISH COLUMBIA / January 10, 2019 / Abattis Bioceuticals Corp (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to announce that, further to its new release dated December 7, 2018, the Company has entered into a definitive share […]

Read More

Abattis Provides Marketing and Operational Updates

Abattis Provides Marketing and Operational Updates December 21, 2018    |    Abattis Bioceuticals VANCOUVER, BRITISH COLUMBIA / December 21, 2018 / Abattis Bioceuticals Corp (the “Company” or “Abattis“) (CSE:ATT) (OTC:ATTBF) is pleased to announce the launch of its new website and provide an operational update. Launch of New Marketing Materials Abattis has recently unveiled […]

Read More

Comfort Launch by Vergence Naturals Exceeds Expectations

Comfort Launch by Vergence Naturals Exceeds Expectations Decmber 11, 2018    |    Abattis Bioceuticals VANCOUVER, BRITISH COLUMBIA / December 11, 2018 / Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to provide an update on the recent soft-launch of its cannabinoid-infused nutraceutical Comfort (“Comfort”) through the Company’s wholly-owned subsidiary, Vergence Naturals […]

Read More

Abattis Announces Acquisition of Fertilizer Company Nutrivida

Abattis Announces Acquisition of Fertilizer Company Nutrivida Decmber 07, 2018    |    Abattis Bioceuticals VANCOUVER, BRITISH COLUMBIA / December 7, 2018 / Abattis Bioceuticals Corp (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to announce that it has signed a non-binding letter of intent dated December 6, 2018 (the “LOI”)  to acquire 100% interest […]

Read More

Abattis Bioceuticals Comments on BCSC Temporary Order

Abattis Bioceuticals Comments on BCSC Temporary Order November 27, 2018    |    Abattis Bioceuticals VANCOUVER, BRITISH COLUMBIA / November 27, 2018 / Abattis Bioceuticals Corp (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) comments on the news release regarding the British Columbia Securities Commission (“BCSC”) Temporary Order dated November 26, 2018. The BCSC issued a temporary […]

Read More
1 2 3 10